Is the Dog Aging Project Legit? What the Study Really Is

Yes. The Dog Aging Project is a real, large-scale scientific study of aging in companion dogs, led by academic researchers and headquartered at the University of Washington in partnership with Texas A&M University. It has received federal research funding through the National Institute on Aging at the National Institutes of Health, it publishes in peer-reviewed journals, and its official website is dogagingproject.org. Enrollment is free, nobody is asked to buy anything, and participation happens mostly online through an owner portal.

The Dog Aging Project is a university-run, peer-reviewed research study — not a marketing front, not a supplement company in disguise, and it never charges you to take part.

If you landed here because a friend forwarded a link, or because the name sounded a little too good to be true, the short version is that the skepticism is healthy and the study holds up to it. Here is what it actually does, how to join or log back in, and what its published work has reported so far.

What the study is and who is behind it

The Dog Aging Project is a long-term observational study — what scientists call a longitudinal cohort — that follows tens of thousands of pet dogs over the course of their lives. Owners enroll their own dogs and then answer detailed surveys year after year. Over time, that creates a dataset linking a dog's genetics, diet, activity, environment, medical history and household circumstances to how that dog ages.

It was co-founded by Daniel Promislow, a biologist who studies the genetics of aging, and Matt Kaeberlein, a biogerontologist whose lab worked on the biology of lifespan. Kate Creevy, a veterinary internal medicine specialist at Texas A&M University, serves as the project's chief veterinary officer. The research is reviewed by institutional oversight committees, consent is documented, and the project operates on an open-science model: curated versions of the data are released to qualified researchers outside the project so other labs can analyze it independently.

The reason companion dogs are such a useful model is straightforward. Dogs share our homes, our air, our water, our couches and in many cases our schedules. They develop many of the same age-related conditions people do — osteoarthritis, cancer, cognitive decline, heart disease — but they do it on a compressed timeline. A study that would take sixty years in humans can be done in a fraction of that in dogs, and the environmental exposures are far easier to measure because the dog lives where the owner lives.

How to tell a legitimate research study from a lookalike

This is worth spelling out, because pet-related scams are common and "join our study" is an easy disguise. The credibility signals to look for are the same ones this project satisfies:

• Named institutional home. You can find the researchers' faculty pages at their universities and read their other published work.
• Peer-reviewed output. The project's design and open-science data approach have been described in the peer-reviewed literature, including in Nature, and its analyses appear in veterinary and gerontology journals.
• Identifiable public funding. Federal grant support through the National Institute on Aging is a matter of public record.
• No payment to participate. A real study does not ask you to pay to be in it. The project does solicit philanthropic donations — openly, and separately from enrollment — but donating is never a condition of taking part.
• Nothing is being sold to you. Enrollment does not come with a product, a subscription, or an upsell.
• Documented consent and data policies. You are told what data is collected and how it is used before you agree.

The practical risk is not the study itself but imitation. Go directly to dogagingproject.org rather than following a link from a social post, an ad, or an unexpected email. If a page asks for payment details, a credit card to "verify" your dog, or login credentials for an unrelated account, close it. The genuine site asks for information about your dog, not your wallet.

It is also fair to note that the project has been public about funding pressure over the years and has appealed for donor support to keep the cohort running. That is ordinary for academic research and is not a mark against its legitimacy — but it does mean enrollment status, cohort recruitment and eligibility can change. Check the official site for what is currently open rather than relying on an article, including this one.

Enrolling, the login portal, and what taking part involves

Enrollment starts by nominating your dog on the official website. You create an owner account, and from then on the portal is where everything happens: completing surveys, updating your dog's information, and uploading or authorizing release of veterinary records. If you cannot log in, use the password reset on the official site or the project's contact form — there is no separate third-party login, and no legitimate reason for anyone to email you asking for your credentials.

Eligibility depends on where you live and on your dog meeting the project's current criteria, which are listed on the site. Any dog can be nominated regardless of age, size, breed, mixed heritage or health status — healthy dogs and sick dogs both contribute useful information.

One of the most common searches is for a Dog Aging Project location near you. There generally isn't one in the way people expect. The core of the study is remote and survey-based, so your dog never has to travel to a research facility. Where physical samples or examinations are involved, they are arranged through your own primary care veterinarian or a participating veterinary practice, not a central campus.

Participation is tiered, and most enrolled dogs stay in the first tier for life:

Level of participation	What it involves	Who it applies to
The Pack (survey cohort)	An annual Health and Life Experience Survey completed online by the owner; no clinic visit required	Every enrolled dog
Veterinary record sharing	You authorize release of your dog's records from your own veterinarian	Most enrolled dogs
Precision cohort	Biological samples — blood, urine, stool, hair — collected through a veterinary visit	A selected subset, by invitation
TRIAD	A randomized, double-blinded, placebo-controlled trial testing rapamycin in older dogs, run at participating veterinary sites	Dogs meeting specific trial criteria

The survey is long. That is the honest trade-off: the scientific value of the cohort depends on the depth of what owners report, so expect to set aside real time for the first one. Subsequent annual surveys are shorter updates.

What the research has reported so far

Because this is an observational cohort, most published findings describe associations rather than proven cause and effect — a distinction the researchers themselves are careful about. With that framing, the project's analyses have examined questions owners genuinely care about: how feeding frequency relates to owner-reported health measures, how physical activity relates to signs of cognitive dysfunction in older dogs, how a dog's environment and household circumstances track with health outcomes, and how owner-reported mobility and pain change with age and body size.

The project has also built out a measure of canine cognitive dysfunction that owners can complete at home, which has made it possible to study dementia-like decline across a very large population of dogs rather than in a handful of referral cases.

The headline intervention work is TRIAD — the Test of Rapamycin in Aging Dogs. Rapamycin is a prescription drug that has extended lifespan in laboratory animals in multiple independent experiments, and TRIAD is testing, under placebo-controlled conditions, whether low-dose rapamycin affects heart function, cognition, activity and lifespan in older large-breed dogs. Results from a trial of that design take years to mature, and no conclusion should be drawn ahead of them.

If you want the findings firsthand, the project maintains a publications list on its site, and many of the papers are open access.

Where everyday care fits while the science matures

None of this changes what sits in front of you tonight: a dog who is maybe a little stiffer getting off the floor than last year. The levers with the strongest evidence behind them are unglamorous and worth taking seriously — keeping lean body condition, consistent low-impact movement, dental care, and regular veterinary exams so that arthritis, endocrine disease and pain are caught and treated early. Talk to your veterinarian about a senior screening schedule; that conversation does more for an aging dog than any product on a shelf.

Inside the space proper veterinary care creates, a lot of owners also look at targeted support — and this is where the supplement aisle earns its bad reputation. Kitchen-sink senior chews stuffed with a dozen ingredients behind a proprietary blend, no batch testing, and no way to know what is actually in the bag are the real credibility problem in this category, not the science of aging.

K9-REPAIR from pawgen takes a narrower approach: two peptides, BPC-157 and TB-500, dosed by body weight. BPC-157 is a synthetic peptide studied in preclinical models for its role in angiogenesis and tissue-repair signaling; TB-500 is a synthetic fragment related to thymosin beta-4, studied for its role in actin regulation and cell migration — the cellular machinery behind how connective tissue remodels after injury. Research suggests these pathways matter in tendon, ligament and soft-tissue recovery, and owners report using the combination through rehab periods and into a dog's older years. This is emerging and promising science that owners are actively adopting. BPC-157 and TB-500 are not FDA-approved veterinary drugs, nothing here is a treatment for any condition, and the right approach for your individual dog — including anything weight-based — is a conversation to have with your veterinarian, not a number to take from a website.

Key Takeaways

• The Dog Aging Project is a legitimate academic study based at the University of Washington with Texas A&M University, supported by federal research funding and publishing peer-reviewed work.
• The official website is dogagingproject.org. Enrollment is free; the project accepts donations but never requires payment to participate.
• Participation is mostly remote through an online owner portal, with annual surveys. There is no walk-in research location, and sample collection happens through veterinary practices.
• A subset of dogs is invited into deeper cohorts, including TRIAD, a placebo-controlled trial of rapamycin in older dogs.
• Published findings so far describe associations — around feeding patterns, activity, environment and cognitive decline — not established cures.
• If a site asks for payment or login credentials to "enroll" your dog, it is not the real study.

For what it's worth on the product side: pawgen publishes third-party certificates of analysis for its batches, lists the full K9-REPAIR formulation and its 60-day money-back guarantee in the shop, and sets out where it ships direct to your door.

Your veterinarian owns the diagnosis and the treatment plan — the imaging, the pain protocol, the surgical decision, the prescriptions. Research projects like this one widen what the profession knows about aging dogs, and supplements and peptides operate in the space that good veterinary care creates. Bring your questions, including the ones you got from a study survey or an article like this, to the person who has actually examined your dog.

Owners exploring peptide support for their dog can review K9-REPAIR — BPC-157 + TB-500 formulated for dogs — at https://pawgen.com/. BPC-157 and TB-500 are not FDA-approved veterinary drugs. Nothing in this article treats, cures or prevents any condition; every decision about your dog's care belongs with your veterinarian.